
Source: WHO
Disclaimer: Copyright infringement not intended.
Context
Details
| 
 Aspect  | 
 WHO Priority Medical Devices List (MDL)  | 
 WHO Essential Medicines List (EML)  | 
| 
 Purpose  | 
 To identify critical medical devices needed for safe, effective, and quality health services.  | 
 To list essential medicines that address the priority health needs of the population.  | 
| 
 Scope  | 
 Includes diagnostic, therapeutic, and supportive devices across various health conditions.  | 
 Covers medicines for primary, secondary, and tertiary care levels for various diseases.  | 
| 
 Historical Background  | 
 The concept emerged in 2017 to support countries in providing essential health services.  | 
 The first list was published in 1977 with 208 medicines to standardize and improve global health care.  | 
| 
 Frequency of Updates  | 
 Periodically updated based on advancements and health needs.  | 
 Updated every two years by an expert committee.  | 
| 
 Criteria for Inclusion  | 
 Devices are selected based on safety, efficacy, cost-effectiveness, and public health relevance.  | 
 Medicines are chosen for their relevance, efficacy, safety, and cost-effectiveness.  | 
| 
 Structure  | 
 Divided into categories like diagnostics, anesthesia, surgery, and laboratory services.  | 
 Divided into core and complementary lists based on essential health needs and resources required.  | 
| 
 Current Edition  | 
 As of 2023, the list is periodically reviewed with the latest recommendations.  | 
 The 23rd edition was released in 2023, with 591 drugs and 103 therapeutic equivalents.  | 
| 
 Impact  | 
 Assists countries in planning and providing essential medical devices to improve healthcare delivery.  | 
 Guides national policies and procurement, promoting access to essential medicines worldwide.  | 
| 
 Implementation  | 
 Adaptable to various health system contexts, focusing on the most critical health needs.  | 
 Countries use it to develop their national lists, reflecting local priorities and health conditions.  | 
Key Features
Benefits
Challenges
Sources:
| 
 PRACTICE QUESTION Q: Consider the following statements regarding the MeDevIS platform: 
 Which of the statements given above is/are correct? a) 1 and 2 only Answer: a)  | 
								
								
								
								
								
								
								
				© 2025 iasgyan. All right reserved